The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer who have progressed after prior VEGFR-targeted therapy: Results from the phase 3 COSMIC-311 trial.
 
Marcia S. Brose
Honoraria - Bayer; Eisai; Lilly
Consulting or Advisory Role - Bayer; Blueprint Medicines; Eisai; Exelixis; Lilly; Loxo
Research Funding - Bayer (Inst); Blueprint Medicines (Inst); Eisai (Inst); Exelixis (Inst); Lilly (Inst); Loxo (Inst)
 
Bruce Robinson
Leadership - Cochlear; Mayne Pharma
Stock and Other Ownership Interests - Cochlear; Mayne Pharma
Consulting or Advisory Role - Eisai; Loxo
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Eisai
 
Steven I. Sherman
Honoraria - Eisai
Consulting or Advisory Role - Exelixis; Lilly; Loxo
Research Funding - Exelixis (Inst)
 
Barbara Jarzab
Honoraria - Sanofi
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Exelixis
Travel, Accommodations, Expenses - Ipsen; Sanofi
 
Chia-Chi Lin
Honoraria - Daiichi Sankyo; Lilly; Novartis; Novartis; Roche
Consulting or Advisory Role - Blueprint Medicines; Boehringer Ingelheim; Daiichi Sankyo; Novartis
Travel, Accommodations, Expenses - BeiGene; Daiichi Sankyo; Daiichi Sankyo; Lilly; Novartis
 
Fernanda Vaisman
No Relationships to Disclose
 
Ana Hoff
No Relationships to Disclose
 
Erika Hitre
No Relationships to Disclose
 
Daniel W. Bowles
No Relationships to Disclose
 
Leonardo Faoro
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Kamalika Banerjee
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Jennifer Oliver
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis; Exelixis (I)
 
Bhumsuk Keam
Honoraria - AstraZeneca; Merck; MSD Oncology
Consulting or Advisory Role - ABL Bio; AstraZeneca; CBS Bioscience; Cellid; Genexine; Handok; MSD Oncology
Research Funding - AstraZeneca; MSD Oncology; Ono Pharmaceutical
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer